Free Trial

Biofrontera (BFRIW) Competitors

$0.09 -0.01 (-14.18%)
As of 07/7/2025 10:54 AM Eastern

BFRIW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, AMPE, ACABW, BTMDW, BCTXW, and CALA

Should you be buying Biofrontera stock or one of its competitors? The main competitors of Biofrontera include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Ampio Pharmaceuticals (AMPE), Atlantic Coastal Acquisition Corp. II (ACABW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry.

Biofrontera vs. Its Competitors

Biofrontera (NASDAQ:BFRIW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, media sentiment, profitability, risk and earnings.

In the previous week, Biofrontera's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
180 Life Sciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$38.00MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
180 Life Sciences N/A N/A N/A

Summary

Biofrontera beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Biofrontera News Delivered to You Automatically

Sign up to receive the latest news and ratings for BFRIW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BFRIW vs. The Competition

MetricBiofronteraDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.13B$5.52B$9.03B
Dividend YieldN/A2.92%5.24%4.08%
P/E RatioN/A4.1527.1920.04
Price / SalesN/A563.67413.81108.86
Price / CashN/A10.3526.2128.59
Price / BookN/A11.477.925.55
Net IncomeN/A$21.15B$3.17B$248.49M
7 Day PerformanceN/A1.58%1.78%4.87%
1 Month PerformanceN/A6.44%1.26%6.63%
1 Year PerformanceN/A3.60%33.30%20.38%

Biofrontera Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BFRIW
Biofrontera
N/A$0.09
-14.2%
N/A+157.7%$0.00$38.00M0.0070Positive News
Gap Up
ATNFW
180 Life Sciences
N/A$0.01
-4.7%
N/A-4.6%$0.00N/A0.007Positive News
Gap Up
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/A-80.9%$0.00N/A0.002
AIMDW
Ainos
N/A$0.12
-7.7%
N/AN/A$0.00$106.21K0.0040Gap Down
ALVOW
Alvotech
N/A$1.73
+1.8%
N/A-36.2%$0.00$585.60M0.004Positive News
AMPE
Ampio Pharmaceuticals
0.1435 of 5 stars
$0.00
-96.3%
N/A-96.0%$0.00N/A0.0020Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
flat
N/AN/A$0.00N/A0.0015
BTMDW
biote
N/A$0.01
-19.7%
N/AN/A$0.00$199.38M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.06
-16.2%
N/A-71.1%$0.00N/A0.008
CALA
Calithera Biosciences
N/A$0.00
-90.0%
N/A-99.0%$0.00N/A0.0060

Related Companies and Tools


This page (NASDAQ:BFRIW) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners